Cardiovascular complications of COVID-19: toward better understanding, diagnosis, monitoring and management.

Vicenzi, Marco; Ruscica, Massimiliano; Jamialahmadi, Tannaz; Sahebkar, Amirhossein

Vicenzi, Marco; Ruscica, Massimiliano; Jamialahmadi, Tannaz; Sahebkar, Amirhossein.

Vicenzi M; Cardiovascular Disease Unit, Internal Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Ruscica M; Dyspnea Lab, Department of Clinical Sciences and Community Health, Università Degli Studi di Milano, Milan, Italy.
Jamialahmadi T; Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy.
Sahebkar A; Department of Food Science and Technology, Quchan Branch, Islamic Azad University, Quchan, Iran.

Expert Rev Anti Infect Ther ; 20(3): 325-326, 2022 03.

Article in English | MEDLINE | ID: covidwho-1393097

Subject(s)

COVID-19; Cardiovascular Diseases; Heart Failure; COVID-19/complications; Cardiovascular Diseases/diagnosis; Cardiovascular Diseases/epidemiology; Cardiovascular Diseases/etiology; Humans; Pandemics; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cardiovascular Diseases / COVID-19 / Heart Failure Type of study: Diagnostic study / Observational study Topics: Long Covid Limits: Humans Language: English Journal: Expert Rev Anti Infect Ther Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: 14787210.2021.1964695

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google